Ethnicity and discordance in plasma HIV-1 RNA viral load and CD4+ lymphocyte count in a cohort of HIV-1-infected individuals

Journal of Clinical Virology

Volumn 26, Issue 1, 2003, Pages 101-107

  Smith, Penelope R ^a   Sarner, Liat ^a   Murphy, Maurice ^a   James, Beki ^a   Thomas, Janice M ^b   Skinner, Celia J ^a   Aitken, Celia ^a  

^a BARTS HEALTH NHS TRUST   (United Kingdom)

^b ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

Africa; CD4; HIV; Progression; Viral load

Indexed keywords

CD4 ANTIGEN; VIRUS RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGE; AGED; ARTICLE; CAUCASIAN; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE COURSE; ETHNIC DIFFERENCE; ETHNIC GROUP; ETHNOLOGY; FEMALE; GENDER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NEGRO; OBSERVATION; PLASMA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RNA ANALYSIS; SUPERINFECTION; UNITED KINGDOM; VIRUS LOAD; VIRUS TRANSMISSION;

ADULT; AFRICA SOUTH OF THE SAHARA; AFRICAN CONTINENTAL ANCESTRY GROUP; CARIBBEAN REGION; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; CONFOUNDING FACTORS (EPIDEMIOLOGY); CROSS-SECTIONAL STUDIES; ETHNIC GROUPS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; LONDON; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RNA, VIRAL; VIRAL LOAD; VIREMIA;

EID: 0037267089     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1386-6532(02)00180-4     Document Type: Article

References (19)

1. Bellamy R., Ruwende C., Corrah T., McAdam K.P.W.J., Thursz M., Whittle H.C., Hill A.V.S. Tuberculosis and chronic hepatitis B virus infection in Africans and variation in the vitamin D receptor gene. J. Infect. Dis. 179:1999;721-724.
2. Bentwich Z., Weisman Z., Grossman Z., Galai N., Kalinkovich A. Pathogenesis of AIDS in Africa: lesson from the Ethiopian immigrants in Israel. The Immunologist. 5:1997;21-26.
3. Brown A.E., Malone J.D., Zhou S.Y.J., Lane J.R., Hawkes C.A. Human immuno-deficiency virus RNA levels in US adults: a comparison based upon race and ethnicity. J. Infect. Dis. 176:1997;794-797.
4. Carpenter C.C.J., Fischl M.A., Hammer S.M., Hirsch M.S., Jacobsen D.M., Katzenstein D.A., Montaner J.S.G., Richman D.D., Saag M.S., Schooley R.T., Thompson M.A., Vella S., Yeni P.G., Volberding P.A. Antiretroviral therapy for HIV infection in 1998. J. Am. Med. Assoc. 280:1998;78-86.
5. Chaisson R.E., Fuchs E., Stanton D.L., Quinn T.C., Hendrickson C., Bartlett J.G., Farzadegan H. Racial heterogeneity of HIV antigenaemia in people with HIV infection. AIDS. 5:1991;177-180.
6. Del Amo J., Petruckevitch A., Phillips A.N., Johnson A.M., Stephenson J.M., Desmond N., Hanscheid T., Low N., Newell A., Obasi A. Spectrum of disease in Africans with AIDS in London. AIDS. 10:1996;1563-1569.
7. Dragic T., Litwin V., Allaway G.P., Martin S.R., Huang Y., Nagashima K., Cayanan C., Maddon P.J., Koup R.A., Moore J.P., Paxton W.A. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature. 381:1996;667-673.
8. Dunne A.L., Crowe S.M. Comparison of branched DNA and reverse transcriptase polymerase chain reaction for quantifying six different HIV-1 subtypes in plasma. AIDS. 11:1997;126-127.
9. Easterbrook P.J., Farzadegan H., Hoover D.R., Palenicek J., Chmiel J.S., Kaslow R.A., Saah A.J. Racial differences in rate of CD4 decline in HIV-1-infected homosexual men. AIDS. 10:1996;1147-1155.
10. Farzadegan H., Hoover D.R., Astemborski J., Lyles C.M., Margolick J.B., Markham R.B., Quinn T.C., Vlahov D. Sex differences in HIV-1 viral load and progression to AIDS. Lancet. 352:1998;1510-1514.
11. Goletti D., Weissman D., Jackson R.W., Graham N.M.H., Vlahov D., Klein R.S., Munsiff S., Ortona L., Cauda R., Fauci A.S. Effect of Mycobacterium tuberculosis on HIV replication: role of immune activation. J. Immunol. 157:1996;1271-1278.
12. Kanki P.J., Hamel D.J., Sankalé J.L., Hsieh C., Thior I., Barin F., Woodcock S.A., Guèye-Ndiaye A., Zhang E., Montano M., Siby T., Marlink R., Ndoye I., Essex M.E., Mboup S. Human immunodeficiency virus type 1 subtypes differ in disease progression. J. Infect. Dis. 179:1999;68-73.
13. Manoff S.B., Farzadegan H., Munoz A., Astemborski J.A., Vlahov D., Rizzo R.T., Solomon L., Graham N.M. The effect of latent Mycobacterium tuberculosis infection on human immunodeficiency virus (HIV) disease progression and HIV RNA load among injecting drug users. J. Infect. Dis. 174:1996;299-308.
14. Mellors J.W., Rinaldo C.R., Gupta P., White R.M., Todd J.A., Kingsley L.A. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science. 272:1996;1167-1170.
15. Meyer L., Maagierowska M., Hubert J., Theodorou I., van Rij R., Prins M., de Roda Husman A.-M., Coutinho R., Schuitemaker H. Early protective effect of CCR-5 Δ32 heterozygosity on HIV-1 disease progression: relationship with viral load. AIDS. 11:1997;F73-F78.
16. Rizzardini G., Trabattoni D., Saresella M., Piconi S., Lukwiya M., Declich S., Fabiani M., Ferrante P., Clerici M. Immune activation in HIV-infected African individuals: Italian-Ugandan AIDS cooperation program. AIDS. 12:1998;2387-2396.
17. Saul J., Erwin J., Sabin C.A., Kulasegaram R., Peters B.S. The relationships between ethnicity, sex, risk group, and virus load in human immunodeficiency virus type 1 antiretroviral-naive patients. J. Infect. Dis. 183:2001;1518-1521.
18. Smith M.W., Dean M., Carrington M., Winkler C., Huttley G.A., Lomb D.A., Goedert J.J., O'Brien T.R., Jacobson L.P., Kaslow R., Buchbinder S., Vittinghoff E., Vlahov D., Hoots K., Hilgartner M.W., O'Brien S.J. Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Science. 277:1997;959-965.
19. Sterling T.R., Chaisson R.E., Moore R.D. HIV-1 RNA, CD4 T-lymphocytes, and clinical response to highly active antiretroviral therapy. AIDS. 15:2001;2251-2257.